king-canute
18 May 2018
Kevin Havelock buys another 9,000 shares Kevin Havelock, Non Executive Director, bought 9,000 shares in the company on the 18th May 2018 at a price of 2806.57p. The Director now holds 19,000 shares.Well at least he is showing confidence that the shares will go higher in price.
Cantseethewoodsforthetrees
17 May 2018
Re: 8%? Drop That seems entirely fair comment.Investors will need to have 'faith' in the management-particularly the new team in the US-and patience to allow them to execute their strategy.Imho about 10% of the sp is trader 'froth', so £27 seems fair value until US figures are published.
king-canute
17 May 2018
Re: 8%? Drop Full link not shown in full yet again, I suggest trying[link]
king-canute
17 May 2018
Re: 8%? Drop Apologies to all, this is the full link to that given in previous comment.[link]
king-canute
17 May 2018
Re: 8%? Drop Shorters may be at work, Fund Manager Barry Norris of Argonaut announced in April he had taken a short position in Fevertree.See also Proactive Investors comment this morning:-Fevertree fails to upgrade expectations in a trading update for first time since listing[link]
pendil
17 May 2018
Re: 8%? Drop I think the market is used to FEVR beating expectations so an "in line' update has disappointed.Also sounds like not much tangible progress - yet - in US. If they can crack that it would be huge.
northern pike hunter
17 May 2018
Re: 8%? Drop Difficult to know what has frightened the horses. The appointment of the new non-exec seems sensible enough. The statement seems reassuringly solid. I've taken the opportunity to top-up.
skimp
17 May 2018
Re: 8%? Drop There seems to be a pattern for a rise then a drop only to climb back again. Could be profit taking but then I'm no analyst. Just a thought.
Chicken Lips
17 May 2018
8%? Drop Any News?
king-canute
10 Apr 2018
Kevin Havelock Non-Executive Director has bought 10,000 shares at an average price of 2,683.26, so he is seemingly optimistic about the future of the company to throw in over £250,000.
bestone
05 Apr 2018
Sugar Tax Price increase due to sugar tax could negatively impact sales. Also I note increased marketing activity from their competitor Schwepps.
Chicken Lips
01 Apr 2018
Sugar Tax Fever raising prices - Times The price of a gin and tonic could rise by more than 11p as bars, pubs and restaurants seek to pass on the cost to consumers. Moscow mules, rum and cokes and Black Russians could also be affected.Fever-Tree, the posh tonic company, said it will charge customers more. For a bottle of original tonic it will raise its charge from £1.69 to £1.80. Its “light” version, which contains 2.9g sugar, will remain unchanged at £1.69 for 500ml.The tax was announced in 2016 by the then chancellor George Osborne in a move backed by the celebrity chef Jamie Oliver. It has been met with criticism from drinks companies.[link]
Chicken Lips
29 Mar 2018
Re: SP The share price seems to be suffereing a similar fate to last year with a dip following execellent results and the potential for US/Europe expansion. The director sale of shares and price perhaps? But we have dipped below £27 not risen to the predicted £30 of a few weeks ago on growth options.
king-canute
25 Mar 2018
Re: Today's Times - avoid The Institutions who snapped up Rolls' shares on offer seem more optimistic.Going back in the last year or so some newspaper columnists have adopted the same view as the Times, yet the price has then doubled. The annual percentage growth increase will slow down of course.
Chicken Lips
25 Mar 2018
Today's Times - avoid The Queen’s Club tennis tournament says much about Britons’ changed drinking habits. A decade ago, chilled lager was the tipple on offer at the annual Wimbledon warm-up, under a tie-up with Stella Artois — but lager is so passé. The tonic water maker Fever-Tree is the new title sponsor of Queen’s, after striking a three-year deal.In little over a decade, Fever-Tree has gone from a start-up to one of the most highly valued companies on the AIM junior market. It was launched in 2005 by Charles Rolls, a former managing director of Plymouth Gin, and Tim Warrillow, an advertising and branding executive.It won distribution deals with supermarkets including Tesco and Sainsbury’s, and in 2014 floated on the stock market at 134p a share.Its growth since then has been meteoric, riding gin’s wave of popularity as millennials switch to premium spirits. Last year gin joined the official basket of goods used by the Office for National Statistics to calculate inflation. Gin sales rose 27% last year, leapfrogging vodka to 51m bottles. Its growth since then has been meteoric, riding gin’s wave of popularity as millennials switch to premium spirits. Last year gin joined the official basket of goods used by the Office for National Statistics to calculate inflation. Gin sales rose 27% last year, leapfrogging vodka to 51m bottles. In the UK, Fever-Tree now commands 39% of the mixers category by value, up from 10% two years ago. It has overtaken the former market leader, the Coca-Cola owned Schweppes.Its business model is ultra lean. Fever-Tree pays others to do its manufacturing and distribution and employs just 60 staff. Also, it is expanding in the US, discussing tie-ups with spirits companies and dealing directly with distribution teams, rather than relying on an agent. That should give it a decent foothold in another market where premium spirits are in the ascendency.Yet Fever-Tree’s share price growth is on another scale altogether. Rolls has been capitalising on its stellar performance, selling a 2.6% stake on Friday to raise £82.5m. That knocked 5% off the share price, though it still ended the week at £28.07, valuing the firm at £3.2bn.That is a 1,994% increase on the float price, and makes Fever-Tree more valuable than market stalwarts such as bookmaker William Hill and the water utility Pennon.All this for a company that posted £170.2m of revenues and £56.4m of profits last year. It trades on a price/earnings multiple of 58 times 2020’s projected earnings; at that level, it is detached from reality.With revitalised competition in Schweppes, which is pouring money into a relaunch of its brand, Fever-Tree cannot bank on its UK growth continuing unchecked.It has been a great ride, but the gin bubble will not last for ever. Avoid.In the UK, Fever-Tree now commands 39% of the mixers category by value, up from 10% two years ago. It has overtaken the former market leader, the Coca-Cola owned Schweppes.[link]
